Search results
As biotech recovers, venture firms’ preferences appear to shift
BioPharma Dive via Yahoo Finance· 3 days agoVenture investment into U.S. biotechs is back at pre-COVID levels. But firms seem more selective in...
How a biotech startup, with fresh cash from key VCs, is using AI to spin macrocycles - San Francisco...
The Business Journals· 4 days agos (Nasdaq: NVDA) NVentures venture capital arm, Menlo Ventures, Madrona Venture Group, Lifeforce...
Be Bio’s haemophilia B treatment gains FDA orphan drug status
Pharmaceutical Technology via Yahoo Finance· 4 days agoEstablished in October 2020, Be Bio has received backing from investors including Alta Partners, ...
What I learned about dealmaking (and mascots) in Japan
Fortune· 5 days agoIn 2023, total VC deal activity in Japan shook out to $5.1 billion in value, across 1,213 deals, according to PitchBook.
Databricks CEO Ali Ghodsi on Snowflake rivalry and the ‘why’ behind Databricks’ latest...
Fortune· 4 days agoDatabricks just acquired open source-focused data manager Tabular. Though we don’t know the exact contours of the deal, we know it’s north of $1 billion, making it the company’s second billion-dollar deal within 12 months.
Biotech company Vilya lands cash for disease-fighting 'macrocycles' - Puget Sound Business Journal
The Business Journals· 4 days agoVilya Inc., a biotech startup based Seattle and with operations in South San Francisco, California,...
NVIDIA and top VC firms invest in Vilya, a biotech spinout from Seattle’s Institute for Protein...
GeekWire· 4 days agoVilya’s backers include biotech investor ARCH Venture Partners, as well as NVIDIA’s venture capital...
J&J-backed Rapport Therapeutics valued at $636.8 million in lukewarm debut
Reuters via Yahoo News· 1 day agoU.S. IPOs are seeing a rebound this year, after an almost two-year dry spell when high interest rates, market volatility and geopolitical turmoil marred investors' risk appetite. Among other ...
Bill Ackman Wants Your Money. Should You Buy Pershing Square USA?
Barrons.com· 1 day agoTax expert Robert Willens says the tax treatment “is not the ideal scenario for U.S. investors.” But...
Pershing Square Holdings Notes the Sale by Pershing Square Capital Management of 10% Common Equity...
Investing.com· 6 days agoPershing Square Holdings, Ltd. today noted that Pershing Square Capital Management, L.P. (“PSCM”),...